Compile Data Set for Download or QSAR
maximum 50k data
Found 6 of ic50 for monomerid = 199945
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM199945(US9226923, 3)
Affinity DataIC50:  1.20nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [C1156Y](Homo sapiens (Human))
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM199945(US9226923, 3)
Affinity DataIC50: <1.20nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor(Homo sapiens (Human))
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM199945(US9226923, 3)
Affinity DataIC50:  1.40nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase receptor(Homo sapiens (Human))
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM199945(US9226923, 3)
Affinity DataIC50:  1.5nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetALK tyrosine kinase receptor [L1196M](Homo sapiens (Human))
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM199945(US9226923, 3)
Affinity DataIC50:  1.80nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
Nanjing Allgen Pharma

US Patent
LigandPNGBDBM199945(US9226923, 3)
Affinity DataIC50:  8.90nMAssay Description:The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ...More data for this Ligand-Target Pair
In DepthDetails US Patent